Back
Marker Therapeutics Stock Price Chart
Today's Fastest Growing Company Might Surprise You
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
26
MRKR
Marker Therapeutics
Last Price:
$2.83
Seasonality Move:
17.02%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRKR is experiencing selling pressure, which indicates risk of future bearish movement.
Marker Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.23 | Sell |
| 20-day SMA: | 3.69 | Sell |
| 50-day SMA: | 3.63 | Sell |
| 200-day SMA: | 3.91 | Sell |
| 8-day EMA: | 3.24 | Sell |
| 20-day EMA: | 3.46 | Sell |
| 50-day EMA: | 3.54 | Sell |
| 200-day EMA: | 3.76 | Sell |
Marker Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 40.58 | Sell |
| Chaikin Money Flow: | -31309 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.19 - 4.11) | Sell |
| Bollinger Bands (100): | (2.86 - 3.92) | Sell |
Marker Therapeutics Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Marker Therapeutics Stock
Is Marker Therapeutics Stock a Buy?
-
Marker Therapeutics share price is 2.98 while MRKR 8-day simple moving average is 3.23, which is a Sell signal.
-
The stock price of MRKR is 2.98 while Marker Therapeutics 20-day SMA is 3.69, which makes it a Sell.
-
Marker Therapeutics 50-day simple moving average is 3.63 while MRKR share price is 2.98, making it a Sell technically.
-
MRKR stock price is 2.98 and Marker Therapeutics 200-day simple moving average is 3.91, creating a Sell signal.
MRKR Technical Analysis vs Fundamental Analysis
Sell
26
Marker Therapeutics (MRKR)
is a Sell
Is Marker Therapeutics a Buy or a Sell?
-
Marker Therapeutics stock is rated a SellThe current Marker Therapeutics [MRKR] share price is $2.98. The Score for MRKR is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
Marker Therapeutics Stock Info
Market Cap:
31.9M
Price in USD:
2.98
Share Volume:
35K
Marker Therapeutics 52-Week Range
52-Week High:
5.99
52-Week Low:
2.44
Sell
26
Marker Therapeutics (MRKR)
is a Sell
Marker Therapeutics Share Price Forecast
-
What is the Marker Therapeutics stock price today?The Marker Therapeutics stock price is 2.98 USD today.
-
Will MRKR stock go up or go down?Marker Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Marker Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Marker Therapeutics is overvalued.
Is Marker Therapeutics Stock a Buy?
-
Marker Therapeutics share price is 2.98 while MRKR 8-day exponential moving average is 3.24, which is a Sell signal.
-
The stock price of MRKR is 2.98 while Marker Therapeutics 20-day EMA is 3.46, which makes it a Sell.
-
Marker Therapeutics 50-day exponential moving average is 3.54 while MRKR share price is 2.98, making it a Sell technically.
-
MRKR stock price is 2.98 and Marker Therapeutics 200-day simple moving average is 3.76, creating a Sell signal.
Fundamental Analysis of Marker Therapeutics
Is Marker Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.14 per share, and a decrease next year of $0.40 per share.
Technical Analysis of Marker Therapeutics
Should I short Marker Therapeutics stock?
-
MRKR Moving Average Covergence Divergence (MACD) indicator is -0.15, suggesting Marker Therapeutics is a Sell
-
Marker Therapeutics Relative Strength Index (RSI) is 40.58, which suggest Marker Therapeutics is oversold
-
The Bollinger Bands (25) for Marker Therapeutics is (3.19 - 4.11), which suggest Marker Therapeutics is a Sell
-
The Bollinger Bands (100) for Marker Therapeutics is (2.86 - 3.92), which suggest Marker Therapeutics is a Sell
* Marker Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.